Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain

Inclusion Criteria:

• Previously diagnosed with idiopathic peripheral neuropathy by a suitably qualifiedand licensed health professional within the past 6 months.

• Over the age of 22 years of age

• Able to read and write English

• Constant feet pain on-going over at least the past 3 months

• Subjects using analgesics (pain medication) must be on a stable analgesic regimen (i.e., no changes to the prescribed analgesic regimen) over a period of at least 14days prior to study enrollment; and be willing and able to not have planned upwarddose titration of analgesics during the study period. Decreasing frequency ofanalgesic use during the study is permitted. Cannabis prescribed for medicinalpurposes qualifies as an analgesic in this context

• Willing and able to refrain from engaging in any non-study therapies for themanagement of foot pain throughout the course of study participation, includingconventional therapies such as physical therapy, occupational therapy, hot or coldpacks, and alternative therapies such as chiropractic care and acupuncture

• Agrees to refrain from taking a dosage of analgesic (pain medication) for at least 6hours before a scheduled VAS foot pain rating is to be recorded

• Subject's degree of foot pain on the 0-100 VAS, with "0" being no pain and "100"being worst pain imaginable, is 50 or greater

Exclusion Criteria:

• Diabetic, referred to as having hemoglobin A1c (HbA1C) of 6.5% or higher

• Previously diagnosed with any definitive (i.e. not idiopathic) cause of peripheralneuropathy by a suitably qualified and licensed health professional within the past 6 months, such as diabetes, injury, infection, toxins and poisons, alcoholism,medications such as chemotherapy, autoimmune disorders, etc..

• Pregnant or possibly pregnant, breastfeeding, or planning pregnancy during theintended course of study participation

• Open wounds (sores, cuts, ulcers, etc.) on or around the treatment area on the feet

• Cancerous growths or lesions on or around the treatment area on the feet

• Difficulty with hand dexterity sufficient to negatively impact the ability toadminister treatments with the laser such as from severe arthritis in the hands,Multiple Sclerosis, Cerebral Palsy, Parkinson's Disease, Huntington's Disease, etc.